Read + Share
Amedeo Smart
Independent Medical Education
Harold J, Bellone S, Manavella DD, Mutlu L, et al. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma. Gynecol Oncol 2022;168:157-165.PMID: 36442427
Email
LinkedIn
Facebook
Twitter
Privacy Policy